At ObesityWeek 2024, researchers presented the latest data on treatment regimens for chronic weight management, including GLP ...

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.

Respondents who participated in continuing medical education had the highest familiarity with TD therapies. Managing patients with tardive dyskinesia (TD) requires evolving educational needs, with ...

Prevalence rates increased with age, with CD being higher in males than in females, and varying by race and ethnicity. HealthDay News — An estimated 100,429 youth are living with pediatric ...

Fatigue, sleep disturbance, executive function, and working memory losses were seen more often in the younger patients (18-44 years) compared with older patients. HealthDay News — Younger and ...

While rising postpartum depression rates reflect improved screening and diagnosis, the need now shifts to interventions to prevent and treat the condition. HealthDay News — Diagnosis of ...

High Medicaid reimbursement rates were associated with 24% lower total health care costs and 23% fewer emergency department visits. Higher Medicaid reimbursement rates for psychiatrists are ...

Credit: Getty Images Americans agree more than they might think. Not knowing this jeopardizes the nation's shared values. The United States presents a paradox: Though the media and public opinion ...

Viloxazine ER may reduce body weight by decreasing the impulsivity and compulsivity that contributes to overeating. Relative to placebo, Viloxazine extended-release (viloxazine ER) treatment for ...

Sodium oxybate was significantly more effective at reducing symptoms than placebo for patients with alcohol-responsive LD but not those whose symptoms do not improve with alcohol.

This study emphasizes the importance of the age and timing of menopausal hormone therapy on the risk of cognitive decline after menopause.